Literature DB >> 12161486

Lumbar bone mineral density at final height and prevalence of fractures in treated children with GH deficiency.

Giampiero Igli Baroncelli1, Silvano Bertelloni, Federica Sodini, Giuseppe Saggese.   

Abstract

Lumbar bone mineral density (BMD) by dual energy x-ray absorptiometry was assessed in 46 (29 boys, 17 girls) treated patients with growth hormone deficiency (GHD) at final height, comparing the BMD results with normative data. Prevalence of fractures in patients during treatment and healthy controls (n = 100) during the corresponding time period was assessed. Lumbar BMD values at final height of fractured and fracture-free patients were compared between them. Lumbar BMD corrected for bone area was significantly (P < 0.01) reduced (boys, -0.4 +/- 0.8 Z score; girls, -0.5 +/- 0.7 Z score), but lumbar BMD corrected for bone size (BMDvolume) did not differ [P = not significant (NS); boys -0.2 +/- 1.0 Z score; girls, -0.3 +/- 1.0 Z score] from normal mean. Approximately 22% of patients had reduced lumbar BMD (Z score, -1 to -2). The fact that patients had a complete or partial GHD did not influence lumbar BMD. The prevalence of fractured patients did not differ (P = NS) from that of controls [n = 7 (15.2%) and n = 24 (24.0%), respectively; odds ratio, 1.837]. Lumbar BMDvolume of fractured patients was significantly (P < 0.02) lower than that of fracture-free (n = 39) patients (boys, 0.310 +/- 0.005 and 0.351 +/- 0.032 g/cm(3), respectively; girls, 0.326 +/- 0.027 and 0.382 +/- 0.036 g/cm(3), respectively). The percentage of the fractured patients with lumbar BMDvolume less than 1 SD of normal mean was significantly (P < 0.0001) higher than that of fracture-free patients [n = 6 (85.7%) and n = 4 (10.3%), respectively; odds ratio, 26.092). The fractured patients also showed reduced lumbar BMD corrected for bone area and BMDvolume at the time of fractures (-1.6 +/- 0.4 and -1.5 +/- 0.2 Z score, respectively). The results show that treated patients with GHD have normal mean values of lumbar BMDvolume at final height, but some patients have reduced lumbar BMD (Z score <1) with an increased susceptibility to fractures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161486     DOI: 10.1210/jcem.87.8.8754

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  The effect of growth hormone deficiency on size-corrected bone mineral measures in pre-pubertal children.

Authors:  M Gahlot; R Khadgawat; R Ramot; M Eunice; A C Ammini; N Gupta; M Kalaivani
Journal:  Osteoporos Int       Date:  2011-11-10       Impact factor: 4.507

Review 2.  Indications and strategies for continuing GH treatment during transition from late adolescence to early adulthood in patients with GH deficiency: the impact on bone mass.

Authors:  G Saggese; G I Baroncelli; T Vanacore; L Fiore; S Ruggieri; G Federico
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

3.  Growth hormone effects on cortical bone dimensions in young adults with childhood-onset growth hormone deficiency.

Authors:  L Hyldstrup; G S Conway; K Racz; A Keller; P Chanson; M Zacharin; A L Lysgaard; A H Andreasen; A-M Kappelgaard
Journal:  Osteoporos Int       Date:  2011-11-29       Impact factor: 4.507

Review 4.  Osteoporosis in children and adolescents: etiology and management.

Authors:  Giampiero Igli Baroncelli; Silvano Bertelloni; Federica Sodini; Giuseppe Saggese
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

5.  Bone mineral density in young adult survivors of acute lymphoblastic leukemia.

Authors:  Inas H Thomas; Janet E Donohue; Kirsten K Ness; Donald R Dengel; K Scott Baker; James G Gurney
Journal:  Cancer       Date:  2008-12-01       Impact factor: 6.860

6.  Bone quality assessed by phalangeal quantitative ultrasonography in children and adolescents with isolated idiopathic growth hormone deficiency.

Authors:  M Vignolo; E Di Battista; A Parodi; C Torrisi; F De Terlizzi; G Aicardi
Journal:  J Endocrinol Invest       Date:  2007-06       Impact factor: 4.256

Review 7.  Childhood-onset growth hormone deficiency and the transition to adulthood: current perspective.

Authors:  M Ahmid; S F Ahmed; M G Shaikh
Journal:  Ther Clin Risk Manag       Date:  2018-11-23       Impact factor: 2.423

Review 8.  Growth hormone deficiency during young adulthood and the benefits of growth hormone replacement.

Authors:  M Ahmid; C G Perry; S F Ahmed; M G Shaikh
Journal:  Endocr Connect       Date:  2016-04-29       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.